SOD2 and age-related macular degeneration: The validity of this approach has been illustrated by two recent publications reporting derivation of iPSCs from AMD patients with ARMS2/HTRA1 high‐risk genotypes displaying reduced superoxide dismutase 2 (SOD2) defense, rendering RPE more susceptible to oxidative damage 24, 25.